0000929638-26-003975.txt : 20261021 0000929638-26-003975.hdr.sgml : 20261021 20261021162050 ACCESSION NUMBER: 0000929638-26-003975 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261021 DATE AS OF CHANGE: 20261021 EFFECTIVENESS DATE: 20261021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trellis Bioscience, Inc. CENTRAL INDEX KEY: 0001162015 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-602061 FILM NUMBER: 261475941 BUSINESS ADDRESS: STREET 1: 1505-B O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-616-1100 MAIL ADDRESS: STREET 1: 1505-B O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: TRELLIS BIOSCIENCE LLC DATE OF NAME CHANGE: 20111108 FORMER COMPANY: FORMER CONFORMED NAME: TRELLIS BIOSCIENCE INC DATE OF NAME CHANGE: 20011108 D 1 primary_doc.xml X0708 D LIVE 0001162015 Trellis Bioscience, Inc. 702 Marshall Street Suite 301 Redwood City CA CALIFORNIA 94063 408-772-8049 DELAWARE TRELLIS BIOSCIENCE LLC TRELLIS BIOSCIENCE INC Corporation true Nora Mende 702 Marshall Street Suite 301 Redwood City CA CALIFORNIA 94063 Executive Officer Chief Financial Officer Larry Kauvar 702 Marshall Street Suite 301 Redwood City CA CALIFORNIA 94063 Executive Officer Chief Science Officer Biotechnology Decline to Disclose 06b false 2022-06-01 false true true true Series 2022 Bridge. Includes convertible notes with 20% warrant coverage. false 0 Indefinite 985000 Indefinite false 6 0 0 0 false Trellis Bioscience, Inc. Nora Mende Nora Mende Chief Financial Officer 2026-10-21